Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

As a growing number of patients with multiple myeloma (MM) respond to upfront therapies while eventually relapsing in a time frame that is often unpredictable, attention has increasingly focused on developing novel diagnostic criteria to also account for disease dissemination. Positron emission tomo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Caserta, Enrico, Chea, Junie, Minnix, Megan, Viola, Domenico, Vonderfecht, Steven, Yazaki, Paul, Crow, Desiree, Khalife, Jihane, Sanchez, James F., Palmer, Joycelynne M., Hui, Susanta, Carlesso, Nadia, Keats, Jonathan, Kim, Young, Buettner, Ralf, Marcucci, Guido, Rosen, Steven, Shively, John, Colcher, David, Krishnan, Amrita, Pichiorri, Flavia
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Immunobiology and Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814935/
https://ncbi.nlm.nih.gov/pubmed/29301755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-09-807263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados